Technical Analysis for BLUE - bluebird bio, Inc.

Grade Last Price % Change Price Change
grade D 98.04 0.58% 0.57
BLUE closed up 0.58 percent on Friday, January 17, 2020, on 1.28 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical BLUE trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
MACD Bullish Signal Line Cross Bullish 0.58%
Pocket Pivot Bullish Swing Setup 0.58%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

bluebird bio, Inc., a clinical-stage biotechnology company, focuses on the development, manufacture, and marketing of therapies to treat various human diseases. Its product candidates include Lenti-D to treat patients with childhood cerebral adrenoleukodystrophy (ALD), a hereditary neurological disorder, as well as for the treatment of adult cerebral ALD; and CAR T cells products for treating oncology diseases. The company's product candidates also comprise LentiGlobin vector for the treatment of ß-thalassemia, a hereditary blood disorder; and sickle cell diseases. It has a strategic collaboration with Celgene Corporation to discover, develop, and commercialize disease-altering gene therapies in oncology. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was founded in 1992 and is headquartered in Cambridge, Massachusetts.
Medicine Biotechnology New Jersey Rare Diseases Medical Genetics Celgene Genetic Genealogy Human Diseases Summit

Is BLUE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 163.425
52 Week Low 71.42
Average Volume 1,366,406
200-Day Moving Average 109.71
50-Day Moving Average 84.27
20-Day Moving Average 90.81
10-Day Moving Average 92.14
Average True Range 4.33
ADX 16.13
+DI 25.70
-DI 15.52
Chandelier Exit (Long, 3 ATRs ) 86.37
Chandelier Exit (Short, 3 ATRs ) 97.25
Upper Bollinger Band 97.30
Lower Bollinger Band 84.32
Percent B (%b) 1.06
BandWidth 14.30
MACD Line 2.50
MACD Signal Line 1.93
MACD Histogram 0.5717
Fundamentals Value
Market Cap 4.47 Billion
Num Shares 45.6 Million
EPS -7.33
Price-to-Earnings (P/E) Ratio -13.38
Price-to-Sales 233.66
Price-to-Book 5.18
PEG Ratio 0.31
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 101.75
Resistance 3 (R3) 101.77 100.57 101.13
Resistance 2 (R2) 100.57 99.62 100.55 100.92
Resistance 1 (R1) 99.30 99.04 99.94 99.28 100.72
Pivot Point 98.10 98.10 98.41 98.08 98.10
Support 1 (S1) 96.83 97.15 97.47 96.81 95.36
Support 2 (S2) 95.63 96.57 95.61 95.16
Support 3 (S3) 94.36 95.63 94.95
Support 4 (S4) 94.34